RXST · ISSUER CIK 1111485
RxSight, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 4 RxSight, Inc. insiders reported $0.00 of open-market purchases and $118K of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 4 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$118KInsider selling
−$118KNet open-market
Sep 16, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 202616:25 | Sep 15, 2026 | RXST | See remarks | M · Exercise | $4.34 | +35,168 | 235,516 | +18% | $153K | ||
| Sep 2, 202621:35 | Sep 2, 2026 | RXST | Chief Medical Officer | S · Sell | $6.96 | −5,100 | 71,775 | -7% | −$35K | ||
| Sep 2, 202621:35 | Aug 31, 2026 | RXST | Chief Medical Officer | M · Exercise | — | +13,425 | 76,875 | +21% | — | ||
| Sep 2, 202621:35 | Sep 2, 2026 | RXST | Chief Financial Officer | S · Sell | $6.96 | −7,765 | 25,049 | -24% | −$54K | ||
| Sep 2, 202621:35 | Aug 31, 2026 | RXST | Chief Financial Officer | M · Exercise | — | +20,441 | 32,814 | +165% | — | ||
| Sep 2, 202621:34 | Sep 2, 2026 | RXST | Chief Operating Officer | S · Sell | $6.96 | −2,041 | 81,509 | -2% | −$14K | ||
| Sep 2, 202621:34 | Aug 31, 2026 | RXST | Chief Operating Officer | M · Exercise | — | +5,370 | 83,550 | +7% | — | ||
| Sep 2, 202621:33 | Sep 2, 2026 | RXST | See remarks | S · Sell | $6.96 | −2,041 | 200,348 | -1% | −$14K | ||
| Sep 2, 202621:33 | Aug 31, 2026 | RXST | See remarks | M · Exercise | — | +5,370 | 202,389 | +3% | — |